Skip to main content
. 2020 Sep 24;25(38):1900716. doi: 10.2807/1560-7917.ES.2020.25.38.1900716

Table 6. Costs, RIG administrations and ICER as a result of a 1.5-fold increased rabies vaccination uptake for diverse risk groups, the Netherlands, 2018 .

Risk group Travellers < 35 years Travellers to south-eastern and western Asia Men Travellers to South America Travellers having at least one risk factor Travellers having all risk factors togethera
Additional vaccinated persons 11,970 9,800 8,570 1,800 17,290 3,410
95% UI 2,850–22,100 1,880–18,530 1,280–16,540 −3,280–6,730b 51,60–31,160 −1,750–8,810b
Avoided number of RIG administrations 45 41 29 4 60 16
Additional costs 1,206,000 966,400 867,100 188,900 1,755,100 333,100
95% UI 226,000–2,413,900 421,000–2,290,000 77.400–1,819,800 −391,900–765,300b 482,700–3,341,000 −260,600–941,800b
ICER: Incremental costs per additional vaccinated person 101 99 101 105 102 98
95% UI 82–116 71–116 0.75–118.0 71–151 88–116 26–181
ICER: Incremental costs per avoided RIG administration 26,970 23,760 30,370 46,750 29,220 21,320
95% UI 9,530–52,460 5,790–49,510 5,323–64,110 −129,950–229,830b 14,250–53,000 −24,010–70,190b

ICER: incremental cost-effectiveness ratio; RIG: rabies immunoglobulin; UI: uncertainty interval.

a This group consist of men younger than 35 years travelling to south-eastern and western Asia.

b Owing to low numbers in this specific risk group, the UI are not interpretable.

The table presents averages with 95% UI. Note that in Table 4 total costs per vaccinated persons are presented, whereas in Table 5 the incremental costs per additional vaccinated person are presented, and they are therefore not comparable. For full details see Supplementary Table S3.